Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. QTI
QTI logo

QTI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy QT Imaging Holdings Inc (QTI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
6.960
1 Day change
-0.14%
52 Week Range
7.350
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

QT Imaging Holdings Inc (QTI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has promising technology and a positive analyst rating, the financial performance shows significant losses, and technical indicators are mixed. The lack of strong trading signals and no recent congress trading data further support a cautious approach. Holding the stock or waiting for better financial performance and clearer technical signals is recommended.

Technical Analysis

The MACD is negative and expanding, indicating bearish momentum. RSI is neutral at 39.677, suggesting no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below the pivot level of 6.633, with support at 6.171 and resistance at 7.096.

Positive Catalysts

  • Analyst rating from Lake Street with a Buy rating and a $10 price target.

  • Launch of QT Imaging-Olea Viewer, enhancing clinical efficiency and patient management.

  • Promising technology with potential to become a significant modality in breast cancer screening.

Neutral/Negative Catalysts

  • Financial performance shows significant losses in net income (-862.35% YoY) and EPS (-600.00% YoY).

  • Gross margin decreased by -19.62% YoY.

  • No significant hedge fund or insider trading trends.

Financial Performance

In Q4 2025, revenue increased by 877.57% YoY to $8,275,070, but net income dropped to -$1,388,079 (-862.35% YoY). EPS fell to -0.1 (-600.00% YoY), and gross margin declined to 37.97% (-19.62% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Lake Street initiated coverage with a Buy rating and a $10 price target, citing the company's innovative breast imaging technology and its potential to become a significant player in breast cancer screening.

Wall Street analysts forecast QTI stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast QTI stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 6.970
sliders
Low
0
Averages
0
High
0
0
Current: 6.970
sliders
Low
0
Averages
0
High
0
Lake Street
NULL
to
Buy
initiated
$10
AI Analysis
2026-01-30
Reason
Lake Street
Price Target
$10
AI Analysis
2026-01-30
initiated
NULL
to
Buy
Reason
Lake Street initiated coverage of QT Imaging with a Buy rating and $10 price target. The company's QT Scan delivers true 3D imaging of breast tissue and offers unique characteristics, making it highly attractive to patients and clinicians, the analyst tells investors. The "massive homerun opportunity" for QT is to become a significant modality within breast cancer screening, the analyst added.

People Also Watch